Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC
Jonathan W. Riess(University of California Davis Medical Center), Alexa B. Schrock(GlobalFoundries (United States)), Grace K. Dy(Roswell Park Comprehensive Cancer Center), Russell W. Madison(Foundation Medicine (United States)), Nir Peled(Shaare Zedek Medical Center), José A. Bufill, David R. Gandara(University of California, Davis), John D. McPherson(Baylor College of Medicine), Garrett M. Frampton(Tech Foundation), Primo N. Lara(UC Davis Comprehensive Cancer Center), Sai‐Hong Ignatius Ou(University of California, Irvine Medical Center), Jeffrey S. Ross(Unknown), Siraj M. Ali(UPMC Hillman Cancer Center), Vincent A. Miller(Universidad San Carlos), Philip C. Mack(UC Davis Comprehensive Cancer Center), Philip J. Stephens(United States Department of the Navy), Rebekah A. Burich(UC Davis Comprehensive Cancer Center)
Cited by 236
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
|Genome Medicine|2017|3.7k